Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Thromb Res. 2012 Jan 13;129(6):750–753. doi: 10.1016/j.thromres.2011.12.008

Fig 1c.

Fig 1c

The reduction of tPA release produced by rolipram was mediated by Epac pathway. HBECs were transfected with Epac1 siRNA and then treated with rolipram , Pooled data from three independent experiments. Mean with error bars representing standard deviation. *p<0.05